regadenoson has been researched along with technetium tc-99m tetrofosmin in 8 studies
| Studies (regadenoson) | Trials (regadenoson) | Recent Studies (post-2010) (regadenoson) | Studies (technetium tc-99m tetrofosmin) | Trials (technetium tc-99m tetrofosmin) | Recent Studies (post-2010) (technetium tc-99m tetrofosmin) |
|---|---|---|---|---|---|
| 321 | 53 | 264 | 1,205 | 216 | 192 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bateman, TM; Blackburn, B; Cerqueira, MD; Hendel, RC; Iskandrian, AE; Leppo, JA; Mahmarian, JJ | 1 |
| Ananthasubramaniam, K; Cabrera, R; Dhanalakota, S; Husain, Z; Jacobsen, G; Karthikeyan, AS; Palani, G; Pathmanathan, S | 1 |
| Ananthasubramaniam, K; Bhatti, S; Dhanalakota, S; Hakeem, A; Husain, Z; Jacobsen, G; Palani, G | 1 |
| Bengel, FM; Caobelli, F | 1 |
| Ali, A; Campagnoli, T; Doukky, R; Fughhi, I | 1 |
| Erinne, I; Kempf, J | 1 |
| Corral, F; de la Fuente, C; Del Castillo, S; Fernandez-Vazquez, F; Garrote, C; Iglesias-Garriz, I; Lastra, JA; RodrÃguez, E; Sevilla, A; Vara-Manso, J | 1 |
| Clarkson, S; Hage, FG; Heindl, B; Iskandrian, AE; Joseph, L | 1 |
2 trial(s) available for regadenoson and technetium tc-99m tetrofosmin
| Article | Year |
|---|---|
Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Electrocardiography; Heart; Humans; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Pilot Projects; Purines; Pyrazoles; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2005 |
Impact of a regimented aminophylline administration protocol on the burden of regadenoson-induced ischemia detected by SPECT myocardial perfusion imaging.
Topics: Administration, Intravenous; Aged; Aminophylline; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2017 |
6 other study(ies) available for regadenoson and technetium tc-99m tetrofosmin
| Article | Year |
|---|---|
Hemodynamic response, arrhythmic risk, and overall safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients.
Topics: Adenosine A2 Receptor Antagonists; Aged; Asthma; Atrioventricular Block; Bronchoconstriction; Chi-Square Distribution; Female; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Purines; Pyrazoles; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Tachycardia, Supraventricular; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2012 |
Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction.
Topics: Adenosine A2 Receptor Agonists; Aged; Biomarkers; Cardiovascular Diseases; Electrocardiography; Endpoint Determination; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Purines; Pyrazoles; Radiopharmaceuticals; Risk Factors; Survival Rate; Tomography, Emission-Computed, Single-Photon | 2014 |
Further evidence for the robustness of regadenoson stress myocardial perfusion SPECT: its predictive value for cardiac events in chronic renal failure.
Topics: Adenosine A2 Receptor Agonists; Cardiovascular Diseases; Female; Humans; Kidney Failure, Chronic; Male; Organophosphorus Compounds; Organotechnetium Compounds; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2014 |
Incidental Detection of Locally Progressed Pancreatic Cancer on SPECT Myocardial Perfusion Images.
Topics: Aged, 80 and over; Bile Ducts; Dilatation; Disease Progression; Echocardiography; Humans; Incidental Findings; Liver; Male; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Pancreatic Neoplasms; Perfusion; Purines; Pyrazoles; Syncope; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2020 |
Diagnostic accuracy of regadenoson stress echocardiography: concordance with gated-spect myocardial perfusion imaging.
Topics: Aged; Cardiac-Gated Imaging Techniques; Comorbidity; Echocardiography, Stress; Female; Heart Disease Risk Factors; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Prevalence; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Smoking; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2021 |
Stress cardiomyopathy as a cause of reverse redistribution with Tc-99m tetrofosmin regadenoson-rest myocardial perfusion imaging.
Topics: Humans; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Tomography, Emission-Computed, Single-Photon | 2023 |